Milestone Scientific, Inc
Milestone Scientific Inc. designs and commercializes computer-controlled injection systems for dental and medical use, centered on its Dynamic Pressure Sensing (DPS) platform. The company’s products are intended to make injections more precise, more comfortable, and in some cases virtually painless, while creating recurring revenue from disposable handpieces and related consumables.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueComputer-controlled dental anesthesia devices and related service revenue, including STA and legacy systems.
Single-use handpieces and other recurring consumables sold with dental devices.
Medical devices built on the DPS platform, including CompuFlo and CathCheck.
Consumables and support revenue tied to medical device usage and installations.
Customers
Customers are primarily dentists, dental groups, and dental offices that buy the STA system to improve patient comfort and standardize injection delivery. The medical side serves anesthesiologists and other clinicians using the CompuFlo and CathCheck systems for precise pressure-controlled delivery and verification. The company also sells through distributors internationally, which broadens access to smaller practices and foreign markets.
Buy STA devices and handpieces to improve patient comfort, reduce anxiety, and support repeat consumable purchases.
Purchase devices at scale and drive higher recurring handpiece usage across multiple locations.
Use CompuFlo and CathCheck for precise pressure-sensing delivery and procedural verification.
Buy and resell products in foreign markets to expand reach without a large direct sales force.
Strategy
Management is trying to shift Milestone from a research-heavy organization toward a more commercially focused medical device company. Near-term priorities are to grow dental revenue, expand international medical sales, and reduce operating expenses while preserving cash. The company is also emphasizing its DPS platform as a broader technology base for future applications beyond dentistry.
Dental products already generate most revenue and recurring handpiece sales support repeat business.
Foreign markets can broaden the installed base without requiring a large internal sales force.
The company remains dependent on external financing until it can generate positive cash flow.
Geography
2025Milestone sells in the United States and internationally, with management highlighting global expansion as a core objective. In the first half of 2025, international revenue was about $1.9 million and included roughly $110,000 from China, showing that overseas demand is a meaningful part of the mix. The company also launched U.S. e-commerce direct-to-end-user sales, which changed its domestic route to market and reduced reliance on prior distribution arrangements.
Share of the revenue the company reports by geography.
Risks
Milestone remains a going-concern story, with recurring losses and a continuing need for external capital until profitability is achieved, if ever. Its business is also exposed to tariff and import restrictions because it sources essential components from China and sells into foreign markets. Execution risk is high because growth depends on converting a niche technology platform into broader commercial adoption across dental and medical channels.
- Going concern and financing dependenceImpact: CriticalLikelihood: High
The company has recurring operating losses and needs additional capital to fund operations.
Exposure: Cash runway and dilution risk
- Tariffs and trade policy changesImpact: HighLikelihood: High
Management says essential elements are sourced from China and the company has significant foreign sales.
Exposure - Commercial adoption of new devicesImpact: HighLikelihood: High
Revenue depends on clinicians adopting computer-controlled injection systems over manual methods.
Exposure: Dental and medical product uptake
- Research and development funding constraintsImpact: MediumLikelihood: Medium
Reduced government or partner funding could slow product development and collaboration.
Exposure: Pipeline and future product expansion
Accounting
Judgemental itemsDevice sales, disposable handpieces, and service revenue may be recognized at different points in time.
Impact: Affects quarterly revenue mix and gross margin
Management concluded there is substantial doubt about continuing as a going concern.
Impact: Signals financing risk and affects investor interpretation of liquidity
SG&A is split across dental, medical, and corporate, influencing how each business line appears.
Impact: Can affect perceived profitability of each product line
The company is delaying some development work, which affects current-period expense levels.
Impact: Changes reported operating losses and future product investment
Similar listed companies
Publicly listed companies with a comparable business focus.
Milestone Pharmaceuticals Inc.
MIST · Pharmaceutical Preparations
Mesa Laboratories, Inc
MLAB · Industrial Instruments For Measurement, Display, and Control
Mesa Laboratories designs and manufactures life sciences tools and critical quality control solutions used in regulated pharmaceutical, healthcare, and medical device applications.
Merit Medical Systems, Inc
MMSI · Surgical & Medical Instruments & Apparatus
Merit Medical Systems designs, manufactures, and markets proprietary medical devices used in interventional, diagnostic, and therapeutic procedures.
Dynatronics Corp
DYNTQ · Surgical & Medical Instruments & Apparatus
Dynatronics Corp designs, manufactures, and sells restorative medical products used in physical therapy, rehabilitation, orthopedics, pain management, and athletic training.
Nordson Corporation
NDSN · General Industrial Machinery & Equipment, NEC
Globus Medical, Inc
GMED · Surgical & Medical Instruments & Apparatus
Globus Medical is a U.S.-based medical device company focused on musculoskeletal care, with products used in spine, orthopedic trauma, hip, knee, extremity and neurosurgical procedures.
Last updated: 24/09/2026